How have PLUR shares performed in 2024?

Pluri's stock was trading at $4.6360 at the beginning of the year. Since then, PLUR stock has increased by 8.9% and is now trading at $5.05. View the best growth stocks for 2024 here .

Are investors shorting Pluri?

Pluri saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 12,800 shares, a drop of 92.2% from the March 15th total of 163,900 shares. Based on an average trading volume of 26,600 shares, the days-to-cover ratio is presently 0.5 days. Currently, 0.3% of the company's shares are sold short. View Pluri's Short Interest .

When is Pluri's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our PLUR earnings forecast .

How were Pluri's earnings last quarter?

Pluri Inc. (NASDAQ:PLUR) released its earnings results on Monday, February, 12th. The company reported ($0.96) EPS for the quarter. The firm earned $0.11 million during the quarter. Pluri had a negative trailing twelve-month return on equity of 177.94% and a negative net margin of 6,708.40%.

When did Pluri's stock split?

Shares of Pluri reverse split on the morning of Monday, April 1st 2024. The 1-8 reverse split was announced on Monday, April 1st 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, April 1st 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

How do I buy shares of Pluri?

Shares of PLUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:PLUR

Pluri (PLUR) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free PLUR Stock Alerts

$5.05

-0.12 (-2.32%)

(As of 04/18/2024 ET)

Compare

Today's Range: $5.00
▼
$5.19
50-Day Range: $5.00
▼
$8.16
52-Week Range: $3.45
▼
$8.56

Volume: 12,131 shs
Average Volume: 62,461 shs
Market Capitalization: $26.16 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Pluri alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Pluri Stock (NASDAQ:PLUR)

Pluri Inc., a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production. The company's development pipeline includes PLX-PAD, is composed of maternal mesenchymal stromal cells originating from the placenta that is currently under phase III study for orthopedic, phase II study for COVID-19, and phase I/II clinical study for Steroid-Refractory cGVHD indications; and PLX-R18, is composed of fetal MSC like cells originating from the placenta that is currently under phase I study for HCT and pilot study for ARS indications. It is also involved in the development of modified PLX cells. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.

PLUR Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PLUR Stock News Headlines

April 18, 2024 | americanbankingnews.com

Tenaya Therapeutics (NASDAQ:TNYA) and Pluri (NASDAQ:PLUR) Financial Review

April 11, 2024 | msn.com

Packers will face the Eagles in Brazil's first NFL game ever

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 10, 2024 | uk.investing.com

Pluri Inc. announces breakthrough in immune cell therapy production

April 8, 2024 | msn.com

Pluri stock jumps 9% on US patent for immune cell production

April 8, 2024 | globenewswire.com

Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method

April 3, 2024 | investorplace.com

PLUR Stock Earnings: Pluri Reported Results for Q4 2023

March 29, 2024 | msn.com

ReAlta signs deal with NIAID to develop drug for radiation poisoning

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

March 28, 2024 | finance.yahoo.com

Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences

March 28, 2024 | globenewswire.com

Pluri's Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences

March 27, 2024 | globenewswire.com

Pluri Inc. Announces 1-for-8 Reverse Share Split

March 21, 2024 | globenewswire.com

Pluri's Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report

March 19, 2024 | globenewswire.com

Engage with Pluri's Talent: Exciting Conference Appearances Ahead

March 14, 2024 | globenewswire.com

Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing

March 11, 2024 | globenewswire.com

Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation

March 6, 2024 | globenewswire.com

Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board

February 28, 2024 | finance.yahoo.com

Pluri’s Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 Goals

February 28, 2024 | globenewswire.com

Pluri's Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 Goals

February 22, 2024 | msn.com

Stelmine Secures Minuapan for Further Exploration

February 21, 2024 | msn.com

Giant Strides Of Isa Kutepa’s Waltersmith Petroman

February 21, 2024 | finance.yahoo.com

Stelmine increases significantly the length of the gold-bearing corridor at Mercator

February 15, 2024 | finance.yahoo.com

Meatable Strengthens Board of Directors to Accelerate Growth of Breakthrough Food Technology

February 14, 2024 | finance.yahoo.com

Pluri Second Quarter 2024 Earnings: US$0.12 loss per share (vs US$0.24 loss in 2Q 2023)

January 25, 2024 | msn.com

Israel’s cell-based coffee: Sustainable solution to brewing industry challenges?

January 23, 2024 | finance.yahoo.com

Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee Crisis

January 10, 2024 | finanznachrichten.de

Pluri Inc.: Pluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing Organization

See More Headlines

Receive PLUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pluri and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/12/2024
Today: 4/19/2024
Next Earnings (Estimated): 5/14/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Current Symbol: NASDAQ:PLUR
CUSIP: N/A
CIK: 1158780
Web: pluri-biotech.com
Phone: 972747108600
Fax: 972-74-710-8787
Employees: 123
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($4.64)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-28,320,000.00
Net Margins: -6,708.40%
Pretax Margin: -6,850.42%
Return on Equity: -177.94%
Return on Assets: -49.60%

Debt

Debt-to-Equity Ratio: 3.69
Current Ratio: 7.12
Quick Ratio: 7.12

Sales & Book Value

Annual Sales: $357,000.00
Price / Sales: 73.35
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.97 per share
Price / Book: 1.70

Miscellaneous

Outstanding Shares: 5,185,000
Free Float: 3,925,000
Market Cap: $26.18 million
Optionable: Optionable
Beta: 1.45

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Mr. Yaacov Yanay (Age 53)
President, CEO & Director
Comp: $575.93k
Ms. Chen Franco-Yehuda (Age 40)
CFO, Treasurer & Secretary
Comp: $375.24k
Mr. Lior Raviv
Chief Technology Officer
Ms. Efrat Livne-Hadass
Vice President of Human Resources
Dr. Nitsan Halevy M.D.
Chief Medical Officer
Mr. Nimrod Bar Zvi
Chief Commercial Officer

Key Competitors

View All Competitors

Institutional Ownership

Citadel Advisors LLC
Bought 32,279 shares on 2/15/2024
Ownership: 0.139%

View All Institutional Transactions

PLUR Stock Analysis - Frequently Asked Questions

How have PLUR shares performed in 2024?: Pluri's stock was trading at $4.6360 at the beginning of the year. Since then, PLUR stock has increased by 8.9% and is now trading at $5.05.
View the best growth stocks for 2024 here.
Are investors shorting Pluri?: Pluri saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 12,800 shares, a drop of 92.2% from the March 15th total of 163,900 shares. Based on an average trading volume of 26,600 shares, the days-to-cover ratio is presently 0.5 days. Currently, 0.3% of the company's shares are sold short.
View Pluri's Short Interest.
When is Pluri's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our PLUR earnings forecast.
How were Pluri's earnings last quarter?: Pluri Inc. (NASDAQ:PLUR) released its earnings results on Monday, February, 12th. The company reported ($0.96) EPS for the quarter. The firm earned $0.11 million during the quarter. Pluri had a negative trailing twelve-month return on equity of 177.94% and a negative net margin of 6,708.40%.

When did Pluri's stock split?: Shares of Pluri reverse split on the morning of Monday, April 1st 2024. The 1-8 reverse split was announced on Monday, April 1st 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, April 1st 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.
How do I buy shares of Pluri?: Shares of PLUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PLUR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Pluri (PLUR) Stock Price, News & Analysis

About Pluri Stock (NASDAQ:PLUR)

PLUR Stock Price History

PLUR Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

PLUR Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info